Agree, Canada and NZ next month - children only; adult end points missed, sales in these countries were poor after Osiris gained approval. Now Mesoblast have the ip, I don't doubt the technology works but is it effective in the market? previous evidence is questionable. I was hoping Celgene would give it a ringing endorsement but there has been little except a 6 month free extension. I have accepted your point that Mesoblast have worked on this product, so we will see.
Ann: Change in substantial holding, page-28
-
- There are more pages in this discussion • 2 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.19 |
Change
0.085(7.69%) |
Mkt cap ! $1.358B | |||
| Open | High | Low | Value | Volume |
| $1.10 | $1.20 | $1.09 | $13.21M | 11.37M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 15000 | $1.19 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.19 | 75212 | 5 |
View Market Depth
| Last trade - 16.10pm 12/07/2024 (20 minute delay) ? |
| MSB (ASX) Chart |